About Careers MedBlog Contact us

Experimental Antibody Drug Protects Nerves from Multiple Sclerosis

by Dr. Trupti Shirole on April 23, 2015 at 4:25 PM
Font : A-A+

Experimental Antibody Drug Protects Nerves from Multiple Sclerosis

Myelin sheaths are fatty protective covering on nerve cells. They insulate and support axons, the fibers that transmit signals between nerve cells. In multiple sclerosis, immune attack destroys these myelin sheaths. Due to damage of this protective coating, the axons gradually wither away, causing the numbness and muscle spasms that are characteristic of the disease. An experimental antibody drug, called anti-LINGO-1, is aimed at protecting nerves from multiple sclerosis and offers hope for a new way to combat the neurological disease. The antibody drug blocks the LINGO-1 protein which inhibits the production of myelin. In doing so, the drug stimulates the regrowth of the myelin sheath.

Bruce Trapp, neuroscientist at the Cleveland Clinic in Ohio, said, "The 12 drugs approved in the US to treat multiple sclerosis slow this immune attack, although sometimes with dangerous side-effects, but none stops it." The anti-LINGO-1 is being developed by the global biotechnology company Biogen based in Cambridge, Massachusetts. If the initial promising results from the trial are confirmed, it will be the first such myelin-regeneration therapy.


Jack Antel, neurologist at McGill University in Montreal, Canada, said, "Once we get a positive result, the field will move very quickly. It has consistently performed well in animal models and in human cells grown in culture."

The study will be presented at an American Academy of Neurology meeting this week in Washington, DC.

Source: IANS


Recommended Reading

Latest Drug News

How Microrobots Could Help Treat Bladder Diseases?
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
How Can Multivitamin Supplements Slow Cognitive Aging?
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
 Ivosidenib Approved for Acute Myeloid Leukemia & Advanced Cholangiocarcinoma
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
Sacubitril/valsartan Unleashes Hope for Heart Failure Patients
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial
How Does Antibiotic Treatment for Women With Persistent Acne Work?
Acne treatment with anti-hypertensive drug is a valuable alternative to antibiotics, say physicians.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Experimental Antibody Drug Protects Nerves from Multiple Sclerosis Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests